Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Cannabis, Myeloma, Side Effects
Cannabis, Myeloma, Side Effects
Can cannabis manage myeloma side effects? To manage multiple myeloma, patients and survivors must reduce pain and other side effects while enhancing the efficacy of conventional myeloma therapies. According to the research linked below, cannabis can do this.
The video linked below is full of useful information about all things medical marijuana.
Multiple Myeloma Patients Are Finding Hope With Medical Marijuana
I have been living with myeloma since my diagnosis in 1994. In that time, I have watched medical cannabis transform from an illegal recreational drug to a medication that can help MM patients manage their pain and side effects.
I began putting two droppers of Charlotte’s Web CBD oil under my tongue each night before bed about two years ago. No THC. I take CW to help me sleep, and help me manage PTSD that some MM survivors deal with.
man hand holding his nutritional supplemets, healthy lifestyle background.
I’m not saying that cannabis is a silver bullet. I’m saying that cannabis, combined with a host of other complementary therapies such as:
- nutrition
- supplementation
- exercise
together, help me manage my MM as well as the long-term side effects that I struggle with.
Email me at David.PeopleBeatingCancer@gmail.com to learn more about evidence-based complementary therapies to help manage your MM.
Good luck,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies – Current status of preclinical and clinical research
Abstract
“Cannabinoids have attracted increasing attention in cancer research in recent decades. A major focus of current preclinical and clinical studies is on the interactions and potential risks when combined with chemotherapeutic agents, targeted therapies and other anticancer strategies.
Given the extensive preclinical data on
- additive,
- synergistic and, in some cases,
- antagonistic tumor cell killing effects of chemotherapeutic agents and cannabinoids when co-administered,
a critical analysis of these data seems essential. The available data mainly relate to combination treatments for
- glioblastoma,
- hematological malignancies
- and breast cancer,
but also for other cancer types. Such an analysis also appears necessary because cannabinoids are used as an option to treat nausea and vomiting caused by chemotherapy, as well as tumor-related pain, and cancer patients sometimes take cannabinoids without a medical prescription.
In addition, numerous recent preclinical studies also suggest cannabinoid-mediated relief of other chemotherapy-related side effects such as
- peripheral neuropathy,
- nephrotoxicity,
- cardiotoxicity,
- cystitis,
- bladder complications and
- mucositis.
To summarize, the data available to date raise the prospect that cannabinoids may increase the efficacy of chemotherapeutic agents while reducing their side effects.
However, preclinical studies on anticancer interactions are mostly limited to cytotoxicity analyses. An equally thorough investigation of the effects of such combinations on the immune system and on the tumorigenic levels of angiogenesis, invasion and metastasis is still pending.
On this basis, a comprehensive understanding for the evaluation of a targeted additional treatment of various cancers with cannabinoids could be established…”
Patterns, Efficacy, and Cognitive Effects of Medical Cannabis Use in Chronic Musculoskeletal Pain Patients
Abstract
“Background: Medical cannabis (MC) is being used with greater frequency in the management of chronic pain. While its efficacy in pain relief is promising, questions about patterns of use and efficacy warrant further investigation. This study aimed to evaluate long-term MC use patterns, perceived efficacy, and its impact on cognition among patients with chronic musculoskeletal noncancer pain.
Results: A total of 77.5% of patients reported using MC daily or near daily. Topical formulations were most frequently used (63.6%). Approximately half of the respondents were uncertain of their exact tetrahydrocannabinol/cannabidiol (THC/CBD) dosage, with a median oral dose of 10 mg recorded among those who provided estimates.
High levels of perceived efficacy were reported, with over 93% of respondents agreeing or strongly agreeing that MC improved their primary symptoms. Cognitive and motor effects were minimal for most users, with 72.1% reporting no impact.
Furthermore, 79.8% of respondents indicated stable usage patterns over the prior three months, and very few reported a need or external suggestion to reduce MC intake.
Conclusions: Long-term MC use is a stable and well-tolerated option for managing chronic musculoskeletal pain, with high patient-reported efficacy and minimal cognitive impact.
These findings support its role in pain management while highlighting the need for further research on optimal dosing and long-term safety.”
cannabis myeloma side effects cannabis myeloma side effects cannabis myeloma side effects